class 1 (DVT/PE) Flashcards

Jan 9th

1
Q

perfusion

A

the flow of blood through the arteries and capillaries delivering nutrients and oxygen to cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is a deep vein thrombosis (DVT)

A

-disorder involving a thrombus in a deep vein (in the legs)
-commonly the iliac and femoral veins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

risk factors for thromboembolism

A

-fracture of large bones
-prolonged immobility
-heart disease, trauma, post-op or postpartum condition, diabetes mellitus, COPD, dehydration, chemo, CVAD
-pregnancy, obesity, oral B/C, constrictive clothing
-previous Hx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

why is fracture of large bones a risk factor for DVTs

A

high risk d/t decreased mobility and endothelial damage,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

why is heart disease a risk factor for DVTs

A

-issues with valves
-issues with blood pooling (stasis=inc risk for clot)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

if someone is high risk for DVTs what can you do to decrease risk?

A

-educate on mobility within 24h post-op/while hospitalized
-TED stockings
-rotation of ankles/flexion of feet while on bedrest hourly
-intermittent compression devices (ICD) (remove for only 30min at a time for mobilization/assessment)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the triad of virchow

A

-it is needed for a clot to form
1.venus stasis
2.hypercoagulability
3.venous endothelial damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

causes of venous stasis

A

-dysfunctional vein valves
-inactive extremity muscles
-change in unidirectional blood flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

causes of endothelial damage

A

-release of clotting factors
-activation of platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

causes of blood hypercoagulabilioty

A

-imbalance in clotting mechanism (coagulation)
-increase in fibrin production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

clinical manifestations of DVTs

A

-firm edema and swelling of the extremity (unilateral)
-extremity may feel warmer than the unaffected extremity (may have redness)
-superficial veins may be more prominent
-tenderness (do not massage)
-low grade fever
-homan’s sign (calf pain with dorsiflexion of the foot, not a great test and may dislodge the clot)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

diagnostic testing for DVTs

A

-venous doppler ultrasound (used to assess for blockage)
-venogram (x-ray to vie blood flow/block)
-D-dimer (blood test) protein fragment elevated if body cannot dissolve the clot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

treatment to prevent DVTs

A

-prevention from growing and fragmenting (PE)
-prevent recurrent thromboemboli
-prevent post-thrombotic syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is post-thrombotic syndrome

A

when an individual has a DVT for a long time= causes chronic pain, inflammation, and swelling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

treatment for DVTS

A

anticoagulant therapy (continuous heparin infusion and taper off to warfarin)
-thrombolytic therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

goal of treating a DVT

A

-increase blood flow & reduce the clot so the body can dissolve it (may take months)
-usually not removed surgically

17
Q

what is a vena cava filter (IVC filter)

A

-can be placed at the time of a thrombolectomy
-traps large emboli and doesn’t allow it to travel
-placed at the level of the diaphragm in the inferior vena cava via the femoral vein
-prevents pulmonary embolism
-used w/anticoagulant therapy or for people w/ dec platelets (can’t use anticoags)

18
Q

therapeutic range for IV heparin infusion in anticoag therapy

A

levels must be 1.5-2x therapeutic range for anticoagulant therapy

19
Q

what labs should be monitored during anticoag therapy

A

PTT and INR

20
Q

what is a pulmonary embolism

A

an occlusion of a portion of the pulmonary blood vessels by an embolus, usually develop from a thrombi
-the obstructed area has to have diminished or absent blood flow

21
Q

inflammatory process with a PE

A

regional blood vessels and bronchioles constrict, which further increases pulmonary vascular resistence, pulmonary arterial pressure, & right ventricular workload

22
Q

clinical manifestations of PE

A

-depends on size and location of clot
-sudden onset; dyspnea, syncope, pleurisy, tacypnea, tachycardia, hypoxemia, and hypotension
-chest pain (sudden and pleuritic)
-anxiety, fever, apprehesion, cough, diaphoresis, and hemoptysis
-DVT is associated with development of PE
-may have fever, cough up blood, impending doom
-death can occur within 1hr of s&s onset

23
Q

PE assessment & diagnostic testing

A

-early recognition & diagnosis is a priority
-chest x-ray, ECG, peripheral vascular studies, arterial blood gas, ventilation-perfusion scan
-spiral CT of lung
-D-dimer assay

24
Q

treatments for PE

A

-elevate HOB & check o2
-heparin protocol (anticoag therapy)
-may give thrombolytic
-thromboectomy depending on size
-may give morphine
-surgical intervention (pulmonary embolectomy, vena cava filter)

25
Q

medications for anticoag tx

A

heparin
warfarin sodium
enoxaparin

26
Q

medication for thrombolytic tx

A

urokinase
streptokinase
alteplase

27
Q

nursing management for PE

A

-assess vitals & lung sounds
-monitor for hypoxemia, & resp distress
-assess for edema & liver enlorgment
-elevate HOV
-alleviate fear & anxiety
-monitor PT, PTT, INR
-treat pain (morphine)

28
Q

PE prevention strategies

A

-active leg exercises
-early ambulation
-elastic compression stockings
-anticoagulant therapy (weight based, lovenox might not be strong enough)
-sequential compression devices (SCDs)